Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.

S. Friedman,R. Levy,W. Garrett,D. C. Doval,S. Bondarde,T. P. Sahoo,D. Lokanatha,P. K. Julka,K. Shenoy,R. Nagarkar,G. S. Bhattacharyya, K. Kumar,S. Nag, P. R. Mohan, N. R. Narang,D. Raghunadharao, M. Walia,W. Yao,J. Li,T. Emm,S. Yeleswaram,P. Scherle,R. Newton

Cancer research（2009）

Cited 29|Views30
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined